Diligence memo · auto-generated · as of July 1, 2026
General Prognostics, Inc.
General Prognostics, Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
General Prognostics, Inc. operates in Other Health Care, based in Boston.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
General Prognostics, Inc. has raised $810K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $610K on 2020-10-29.
Most recent recorded round closed around 2024-06-28.
Valuation (modeled)modeled
Provath models General Prognostics, Inc. at approximately $849K (range $125K–$2.9M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.33× the median modeled value of Pre-Seed Other Health Care companies in 2022–2024 (288 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 44 months.
Last raise 2.0 yr ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round was 3.1× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 29% of Other Health Care peers (5376 compared).
Modeled value ranks above 5% of those peers.
Closest niche peers: Active Recovery TMS, LLC, Imagen Walled Lake Support Services, LLC, Pinnacle Integrated Medicine, Inc., Choix, Inc., DataBiologics, Inc..
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.